Y. Lubeck

Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?

P. Baas, E. Hooijberg, V. van der Noort, 2022, Lung cancer.

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer

A. Broeks, L. Wessels, D. Vis, 2021, Frontiers in Immunology.

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

H. G. van der Poel, A. Broeks, T. Schumacher, 2020, Nature Medicine.

Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.

H. Horlings, A. Broeks, Z. Trajanoski, 2020, European journal of cancer.

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

Mauro J. Muraro, H. G. van der Poel, W. Zwart, 2020, Nature Communications.

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

A. Broeks, L. Smit, O. Krijgsman, 2021, Nature Communications.